Geron
GERN
#6280
Rank
A$1.25 B
Marketcap
A$1.97
Share price
3.15%
Change (1 day)
-68.04%
Change (1 year)

Geron (GERN) - Total debt

Total debt on the balance sheet as of September 2025 : A$0.18 Billion

According to Geron's latest financial reports the company's total debt is A$0.18 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Geron - Total debt on balance sheet (from 1996 to 2025)

Total debt by year

Year Total debt Change
2024-12-31A$0.19 B55.21%
2023-12-31A$0.12 B53.89%
2022-12-31A$81.92 M8%
2021-12-31A$75.86 M96.28%
2020-12-31A$38.64 M959.53%
2019-12-31A$3.64 M
2018-12-31N/A
2005-12-31A$0.07 M-98.21%
2004-12-31A$4.19 M-49.65%
2003-12-31A$8.32 M-81.97%
2002-12-31A$46.18 M35.33%
2001-12-31A$34.13 M-42.79%
2000-12-31A$59.66 M114.24%
1999-12-31A$27.84 M89.47%
1998-12-31A$14.69 M316.36%
1997-12-31A$3.53 M0.16%
1996-12-31A$3.52 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Eterna Therapeutics
ERNA
A$0.83 M-99.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A$37.54 B 20,357.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
A$0.59 B 223.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Incyte
INCY
A$62.12 M-66.15%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
A$73.61 M-59.89%๐Ÿ‡บ๐Ÿ‡ธ USA